As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys.
At Intra-Cellular Therapies (NASDAQ:ITCI), a filing with the SEC revealed that on Wednesday, Director Christopher D. Alafi purchased 170,000 shares of ITCI, for a cost of $11.73 each, for a total investment of $1.99M. Alafi was up about 18.9% on the buy at the high point of today's trading session, with ITCI trading as high as $13.95 in trading on Monday. Intra-Cellular Therapies is trading up about 10.8% on the day Monday. Before this latest buy, Alafi made one other purchase in the past year, buying $1.26M shares for a cost of $12.56 a piece.
And at Cornerstone Building Brands (NYSE:CNR), there was insider buying on Thursday, by CEO James S. Metcalf who purchased 100,000 shares at a cost of $4.45 each, for a total investment of $444,580. This buy marks the first one filed by Metcalf in the past year. Cornerstone Building Brands is trading up about 6.5% on the day Monday. So far Metcalf is in the green, up about 16.1% on their buy based on today's trading high of $5.16.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.